CHRISTOPHER XIKIS: Open Payments
NPI 1750437695 · SETAUKET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,931 in 60 payments from 12 companies in 2025. Trend: 2023 $20,123 · 2024 $22,371 · 2025 $11,931
Speaker / faculty: $8,895Food & beverage: $1,367Travel & lodging: $1,110Consulting: $560
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $6,342 |
| Gilead Sciences, Inc. | 12 | $4,812 |
| ABBVIE INC. | 19 | $340 |
| Indivior Inc. | 5 | $135 |
| Axsome Therapeutics, Inc. | 6 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Braeburn Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
Products named: VIVITROL, Epclusa, VRAYLAR, SUBLOCADE, MAVYRET, Auvelity, BRIXADI, FANAPT.
Industry payments across NY — which companies pay providers there.
